MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11701-026-03284-x

Медицинская библиотека · Journal of robotic surgery · 2026

Bridging the innovation-evidence chasm: a critical appraisal and roadmap for robotic pancreatic cancer surgery.

Zhu Jinxin, Jiang Jiarui, Liu Muyue, Hu Weikang, Lin Jianzhen, Jiang Kuirong

СтатьяПеревод пока не подготовлен

Аннотация

Pancreatic cancer remains one of the most lethal malignancies globally, with its surgical management undergoing profound transformation driven by minimally invasive approaches, particularly robot-assisted systems. This study employs bibliometric analysis combined with thematic synthesis to delineate the research evolution, knowledge structure, and emerging trends in robot-assisted pancreatic surgery from 1999 to 2025. Using CiteSpace software, we analyzed 202 publications from the Web of Science database. Our analysis revealed a distinct three-phase evolutionary trajectory: an emergence phase (1999–2010) focused on technical feasibility, a rapid development phase (2011–2021) emphasizing procedural standardization, and a recent maturation phase (2022–2025) shifting toward outcome evaluation and collaborative research. The knowledge structure has evolved from a singular surgical focus to a multidimensional network encompassing tumor biology, precision imaging, and patient-centered outcomes. “Robotic surgery” serves as a key bridging node connecting these domains. Burst keyword analysis highlights the recent emergence of “international study group,” “cohort studies,” and “surgical outcomes” as predominant research fronts. Collaborative network analysis reveals the United States as the leading contributor, while Italy and Germany serve as crucial international hubs. China demonstrates substantial research output but limited integration into global collaborative networks. While bibliometric trends reflect significant research momentum and technological convergence, this analysis underscores the persistent gap between technical innovation and robust clinical evidence. Future advancement requires prioritized investment in international multicenter trials, standardized training protocols, and deeper integration of artificial intelligence and molecular navigation technologies to substantiate clinical value and improve patient outcomes in this challenging surgical domain.

Для цитирования: Zhu Jinxin, Jiang Jiarui, Liu Muyue, Hu Weikang, Lin Jianzhen, Jiang Kuirong. Bridging the innovation-evidence chasm: a critical appraisal and roadmap for robotic pancreatic cancer surgery.. Journal of robotic surgery. 2026. DOI: 10.1007/s11701-026-03284-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.